The Invesco NASDAQ Future Gen 200 ETF (the Fund) aims to provide exposure to the Nasdaq Innovators Completion Cap Index (the Index). To achieve this, the Fund allocates at least 90% of its total assets to the securities that comprise the Index. The Index itself is composed of 200 small-capitalization companies, which Nasdaq selects based on the relative value of their patent portfolios compared to their overall market capitalization. These eligible companies are drawn from the Nasdaq Composite Index, specifically excluding those already included in the Nasdaq-100 Index and Nasdaq Next Generation 100 Index. Every company within the Index is equally weighted. Both the Fund and the Index are updated regularly, with rebalancing occurring quarterly and reconstitution happening semi-annually.

Cybin Inc. Common Stock

Agenus Inc.

10x Genomics, Inc.

Newell Brands Inc.

Xencor, Inc.

Precigen, Inc.

TriSalus Life Sciences, Inc.

Neuronetics, Inc.

Iovance Biotherapeutics, Inc.

MillerKnoll, Inc.

Healthcare

Technology

Consumer Cyclical

Industrials

Communication Services

Consumer Defensive

Energy

Basic Materials

Cash & Others

Financial Services

Invesco NASDAQ Future Gen 200 ETF

QQQS Holdings & Sector Breakdown